Dudley J. Pennell, John B. Porter, Maria Domenica Cappellini, Lee Lee Chan, Amal El-Beshlawy, Yesim Aydinok, Hishamshah Ibrahim, Chi-Kong Li, Vip Viprakasit, Mohsen S. Elalfy, Antonis Kattamis, Gillian Smith, Dany Habr, Gabor Domokos, Bernard Roubert, and Ali Taher. 2012. “Deferasirox for up to 3 Years Leads to Continued Improvement of Myocardial T2* in Patients With β-Thalassemia Major”. Haematologica 97 (6). Pavia, Italy, 842-48. https://doi.org/10.3324/haematol.2011.049957.